Dr. Nicolas Flannery Arredondo, MD

Dr. Arredondo practices at Northern Light Mercy Hospital in Portland, Maine.

Dr. Arredondo's NPI, 1952520694, was assigned on April 24, 2007. Dr. Arredondo graduated from Joe R. & Teresa Lozano Long School of Medicine in 2002. Dr. Arredondo's Maine license number on file is MD21958.

Dr. Arredondo's primary practice is Northern Light Mercy Hospital, at 175 Fore River Pkwy, Portland, ME 04102 in Cumberland County. The practice phone is (207) 879-3000.

Dr. Arredondo's primary practice is Northern Light Mercy Hospital in Portland, Maine. Dr. Arredondo is also affiliated with Northern Light Mercy Hospital. The medical group on file is Northern Light Mercy Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arredondo practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Arredondo's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Arredondo is board certified in facs by the ACS. Dmand AI has Dr. Arredondo's licenses on file in 6 states: Maine, Florida, Georgia, Virginia, South Carolina and Washington.

Dmand AI lists back and neck pain treatment without fusion, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and spinal fusion among the conditions Dr. Arredondo treats.

CMS data shows 211 Medicare services from Dr. Arredondo across 9 procedure codes in 2024, for 150 Medicare patients. Medicare paid $45,493 for them.

CMS counts 150 Medicare patients who saw Dr. Arredondo in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have arthritis, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arredondo's median patient age at 66, with 48% women.

In 2024, Dr. Arredondo wrote 22 Medicare Part D claims for 16 patients. 95% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $142 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Arredondo for performance year 2024, reported as part of a group. Dr. Arredondo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arredondo as offering telehealth. CMS counts 54 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Arredondo, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Arredondo in 2011. Dr. Arredondo's most frequent co-authors are Selim Ramin Benbadis, MD, Ali M. Bozorg, MD and Elias Dakwar, MD.

CMS Open Payments shows 81 general payments to Dr. Arredondo from 7 drug and device companies from 2016 to 2024. Royalties and licenses make up the largest share, 76% of the total. Surgalign Spine Technologies, Inc. paid the most, $146,342.

Dmand AI lists 1 award for Dr. Arredondo, most recently CMS Stage 1 EHR in 2013.

Dr. Arredondo graduated from Joe R. & Teresa Lozano Long School of Medicine in 2002. Dr. Arredondo is a member of AANS, ACS and CNS.

Dr. Arredondo is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.